Rezultati

RANK and RANK ligand expression in primary human osteosarcoma od Daniel Branstetter, Kathy Rohrbach, Liya Huang, R Soriano, Mark Tometsko, Michelle Blake, Allison P. Jacob, William C. Dougall

Polni tekst

The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study od Socrates E. Papapoulos, Kurt Lippuner, Christian Roux, Celia J. F. Lin, David L. Kendler, E. Michael Lewiecki, Maria Luisa Brandi, E. J. Czerwiński, Edward Franek, P. Lakatos, C. Mautalén, Salvatore Minisola, Jean‐Yves Reginster, S. Jensen, Nadia Daizadeh, A. Wang, Marc A. Gavin, Cesar Libanati, Rachel B. Wagman, Henry G. Bone

Polni tekst Polni tekst

T-cells and B-cells in osteoporosis od M. Neale Weitzmann

Polni tekst

Comparative Effects of Teriparatide, Denosumab, and Combination Therapy on Peripheral Compartmental Bone Density, Microarchitecture, and Estimated Strength: the DATA-HRpQCT Study od Joy N. Tsai, Alexander V. Uihlein, Sherri‐Ann M. Burnett‐Bowie, Robert M. Neer, Yuli Zhu, Nicholas P. Derrico, Hang Lee, Mary Bouxsein, Benjamin Z. Leder

Polni tekst

Effects of antiresorptive therapies on glucose metabolism: Results from the FIT, HORIZON-PFT, and FREEDOM trials od Ann V. Schwartz, Anne L. Schafer, Andrew Grey, Eric Vittinghoff, Lisa Palermo, Li‐Yung Lui, Robert B. Wallace, Steven R. Cummings, Dennis M. Black, Douglas C. Bauer, Ian R. Reid

Polni tekst

Osteoprotegerin and Denosumab Stimulate Human Beta Cell Proliferation through Inhibition of the Receptor Activator of NF-κB Ligand Pathway od Nagesha Guthalu Kondegowda, Rafael Fenutría, Ilana Pollack, Michael Orthofer, Adolfo García‐Ocaña, Josef Penninger, Rupangi C. Vasavada

Polni tekst

Surgical Downstaging in an Open-Label Phase II Trial of Denosumab in Patients with Giant Cell Tumor of Bone od Piotr Rutkowski, Stefano Ferrari, R. J. Grimer, Paul Stalley, P. D. S. Dijkstra, Andrzej Pieńkowski, Gualter Vaz, Jay S. Wunder, Leanne L. Seeger, Amy Feng, Zachary Roberts, Bruce Allen Bach

Polni tekst Polni tekst

Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 1... od Peyman Hadji, Νικόλαος Παπαϊωάννου, Evelien Gielen, Maurille Feudjo Tepie, E Zhang, Isolde Frieling, Piet Geusens, Polyzois Makras, Heinrich Resch, Gerd Möller, L. Kalouche-Khalil, Astrid Fahrleitner‐Pammer

Polni tekst Polni tekst

The pharmacokinetics and pharmacodynamics of denosumab in patients with advanced solid tumours and bone metastases: a systematic review od Winnie Sohn, Mary Ann Simiens, Kelly Jaeger, Shauna Hutton, Graham Jang

Polni tekst Polni tekst

Bisphosphonates and other bone agents for breast cancer od Brent O׳Carrigan, Matthew H. Wong, Melina L Willson, Martin R. Stockler, Nick Pavlakis, Annabel Goodwin

Polni tekst

RANKL Inhibitors Induce Osteonecrosis of the Jaw in Mice With Periapical Disease od Tara Aghaloo, Simon Cheong, Olga Bezouglaia, Paul J. Kostenuik, Elisa Atti, Sarah Dry, Flávia Q. Pirih, Sotirios Tetradis

Polni tekst

Androgen-deprivation therapy and bone loss in prostate cancer patients: a clinical review od Marc Bienz, Fred Saad

Polni tekst

Denosumab Rapidly Increases Cortical Bone in Key Locations of the Femur: A 3D Bone Mapping Study in Women With Osteoporosis od Kenneth Poole, Graham M. Treece, Andrew H. Gee, Jacques P. Brown, Michael R. McClung, Andrea Wang, Cesar Libanati

Polni tekst Polni tekst

RANKL Inhibition With Denosumab Does Not Influence 3-Year Progression of Aortic Calcification or Incidence of Adverse Cardiovascular Events in Postmenopausal Women With Osteoporosi... od Elizabeth J. Samelson, Paul D. Miller, Claus Christiansen, Nadia Daizadeh, Luanda Grazette, Mary S. Anthony, Ogo Egbuna, Andrea Wang, Suresh Siddhanti, Angela M. Cheung, Nathalie Franchimont, Douglas P. Kiel

Polni tekst

Denosumab: mechanism of action and clinical outcomes od David A. Hanley, Jonathan D. Adachi, Alan Bell, Vivien Brown

Polni tekst

Enhanced Immunoprotective Effects by Anti-IL-17 Antibody Translates to Improved Skeletal Parameters Under Estrogen Deficiency Compared With Anti-RANKL and Anti-TNF-α Antibodies od Abdul Malik Tyagi, Mohd Nizam Mansoori, Kamini Srivastava, Mohd Parvez Khan, Jyoti Kureel, Manisha Dixit, Priyanka Shukla, Ritu Trivedi, Naibedya Chattopadhyay, Divya Singh

Polni tekst Polni tekst

Giant-cell tumor of bone: treatment options and role of denosumab od Sant P. Chawla, Arun S. Singh, Neal Shiv Chawla

Polni tekst Polni tekst

Painful Osseous Metastases od Howard S. Smith

Polni tekst

Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysis od Linda Karlsson, Jonas Lundkvist, E Psachoulia, Michele Intorcia, O. Ström

Polni tekst Polni tekst

Therapeutic Potential of Denosumab in Patients With Lung Cancer: Beyond Prevention of Skeletal Complications od Javier de Castro, Rosario Dueñas García, Pilar Garrido, Dolores Isla, Bartomeu Massutí, Belén Blanca, Jorge Rodriguez Vazquez

Polni tekst Polni tekst